Neurologic and Psychiatric Effects of SARS-CoV-2 Meeting
The National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, and National Institute on Aging conducted a virtual meeting on the neurologic and psychiatric effects of SARS-CoV-2 infection from July 14-15, 2021.
There is emerging data that in as high as 30% of coronavirus disease 2019 (COVID-19) patients, neurologic and psychiatric symptoms are observed. A majority of patients also develop loss of smell and taste, myalgias, and fatigue or malaise. Many patients also experience Post-Acute Sequelae of SARS-CoV-2 infection (PASC).
This meeting examined emerging data related to neurologic and psychiatric complications of SARS-CoV-2 infection and possible interactions with other central nervous system (CNS) infections such as human immunodeficiency virus (HIV). A panel discussed future research gaps and priorities, particularly regarding long-term neurologic and psychiatric complications in relation to PASC.
Division of AIDS Research